General
1 H NMR spectra were recorded at 300 K on a Bruker Avance III 500 at a frequency of 500.13
MHz, a Bruker Avance DPX 400 at a frequency of 400.13 MHz, a Bruker Avance DPX 300 at a frequency of 300. polarimeter at 589 nm. Infrared spectra were recorded on a Bruker Alpha FT-IR spectrometer using attenuated total reflection (ATR) of a thin film.
Low resolution mass spectra were recorded on a Thermo Finnigan LCQ Deca Ion Trap mass spectrometer and high resolution mass spectra were recorded on a 4.7 T Bruker BioApex
Fourier Transform Ion Cyclotron Resonance mass spectrometer (FT-ICR). Ionization of all samples was carried out using electrospray ionisation (ESI) or atmospheric pressure chemical ionization (APCI).
Liquid chromatography mass spectrometry (LCMS) data was obtained on a Shimadzu
Separation Products: Spectra System based on a P400 Pump, a UV6000LP photodiode array detector, a Phenomenex Jupiter column (5 µm, 2.1 × 150mm) and a Thermoquest Finnigan LCQ Deca mass spectrometer (ESI). Flow rate was maintained at 0. Peltier System and pH values were determined using an Activon Model 209 pH/mV meter.
Synthesis

1-(2-Bromoethyl)uracil (15)
Uracil (1.00 g, 8.9 mmol) and ClSiMe 3 (0.54 mL, 4.5 mmol) in hexamethyldisilazane (5.7 mL, 27.0 mmol) were allowed to reflux under argon for 24 h. The reaction mixture was concentrated under reduced pressure and the residue was dissolved in DMF (5 mL) followed by addition of 1,2-dibromoethane (2.3 mL). The resulting mixture was heated at 80 °C for 24
h, cooled and treated with water (80 mL). After filtration, the aqueous filtrate was then extracted with CH 2 Cl 2 (3 x 200 mL). The combined organic extracts were dried over MgSO 4 and concentrated to afford the product 15 (0.60 g, 31% 9, 2.9, 3.9, 4.8, 6.4, 8.0, 9.6, 12.4, 15.1, 19.9, 24.6, 29.4, 39.7, 50 .0 µM in aqueous solutions of HEPES buffer (5 mM, 145 mM NaCl, pH 7.4) at 25 °C, λex = 390 nm, slit 5/5. Inset: 1:1 fitting curve at 480 nm. 
